Donor-derived Anti-CD19 CAR T cells GC007g for relapsed or refractory B-cell acute lymphoblastic leukemia after allogeneic HSCT: a phase 1 trial
-
Published:2024-01
Issue:
Volume:67
Page:102377
-
ISSN:2589-5370
-
Container-title:eClinicalMedicine
-
language:en
-
Short-container-title:eClinicalMedicine
Author:
Luo Yi,
Gao Lei,
Liu Jia,
Yang Luxin,
Wang Lu,
Lai Xiaoyu,
Gao Shichun,
Liu Lizhen,
Zhao Lu,
Ye Yishan,
Wang Manning,
Shen Lianjun,
Cao W. William,
Wang Dongrui,
Li Wenling,
Zhang Xi,
Huang HeORCID